SightLine Partners is a Minnesota-based private equity firm focused on providing secondary liquidity and growth capital to commercial-stage healthcare companies, specializing in medical devices, diagnostics, digital health, and healthcare services.
56% of their portfolio is in Healthcare. Average disclosed round size is $30.0M (across 8 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Magnolia Medical Technologies | Growth | $46M | Feb 2022 |
| Magnolia Medical Technologies | Series C | $20M | Jan 2019 |
 EndoGastric Solutions, Inc. | Series B | $30.5M | Jul 2018 |
 Earlens | Series C | $73M | Jun 2017 |
| CConventus Orthopaedics | Growth | $24M | Jan 2014 |
| LLipoScience | Series F | $13M | Jan 2006 |
 Monteris Medical | Series C | $26.6M | — |
| CConventus Orthopaedics | Bridge | — | — |
| CCelleration | Series D | $7M | — |
Top Co-Investors
CRG2 shared
Insight Partners2 shared
RTW Investments, LP2 shared
HealthQuest Capital2 shared
Blue Sky2 shared
Ally Bridge Group2 shared
Deerfield2 shared
Bling Capital1 shared
New Enterprise Associates1 shared
Scale Venture Partners1 shared
Lightstone Ventures1 shared
Medtronic1 shared
Windham Capital Partners1 shared
Sectoral Asset Management1 shared
Evidity Health Capital1 shared
Radius Capital1 shared
Canaan Partners1 shared
Advanced Technology Ventures1 shared
Chicago Ventures1 shared
Last updated: 7 October 2026